Jan 13 (Reuters) - INTEGRAGEN SA ALINT.PA :
* INTEGRAGEN REPORTS €12.6M IN REVENUES FOR 2022
REPRESENTING 16%
GROWTH COMPARED TO 2021 AND A CASH POSITION OF €4.5M
* GROWTH SUPPORTED BY HIGH-THROUGHPUT GENOMIC SEQUENCING
LABORATORY IN EVRY
* CONFIRMS ITS GROWTH PERSPECTIVES BASED ON CURRENT SALES
DYNAMICS
AND EXISTING LONG-TERM CONTRACTS ALONG WITH SYNERGIES NOW IN
PLACE WITHIN ONCODNA GROUP
Source text for Eikon: ID:nBw4NfK98a
Further company coverage: ALINT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))